Matti Nuutinen

4.1k total citations
86 papers, 2.6k citations indexed

About

Matti Nuutinen is a scholar working on Nephrology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Matti Nuutinen has authored 86 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Nephrology, 21 papers in Molecular Biology and 17 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Matti Nuutinen's work include Renal Diseases and Glomerulopathies (23 papers), Nephrotoxicity and Medicinal Plants (15 papers) and Vasculitis and related conditions (13 papers). Matti Nuutinen is often cited by papers focused on Renal Diseases and Glomerulopathies (23 papers), Nephrotoxicity and Medicinal Plants (15 papers) and Vasculitis and related conditions (13 papers). Matti Nuutinen collaborates with scholars based in Finland, Italy and Norway. Matti Nuutinen's co-authors include Jaana Ronkainen, Matti Uhari, Olli Koskimies, Juha Turtinen, Timo Jahnukainen, Marja Ala‐Houhala, Jukka Rajantie, Pekka Arikoski, Bruno Giardina and Timo Örmälä and has published in prestigious journals such as The Lancet, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Matti Nuutinen

85 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matti Nuutinen Finland 31 928 829 616 396 394 86 2.6k
R. C. Atkins Australia 37 456 0.5× 1.7k 2.1× 960 1.6× 335 0.8× 257 0.7× 88 5.1k
Norman J. Siegel United States 34 459 0.5× 1.2k 1.5× 964 1.6× 189 0.5× 118 0.3× 110 3.0k
Jun Oh Germany 31 391 0.4× 2.1k 2.5× 858 1.4× 248 0.6× 103 0.3× 159 4.0k
Masashi Mizuno Japan 35 387 0.4× 987 1.2× 788 1.3× 247 0.6× 302 0.8× 189 4.2k
R. A. P. Koene Netherlands 29 364 0.4× 654 0.8× 503 0.8× 78 0.2× 475 1.2× 148 3.0k
Marco Carini Italy 40 2.4k 2.6× 592 0.7× 1.8k 2.9× 854 2.2× 174 0.4× 213 7.1k
Deborah P. Jones United States 28 814 0.9× 606 0.7× 520 0.8× 98 0.2× 48 0.1× 67 2.6k
G Richet France 24 442 0.5× 916 1.1× 526 0.9× 270 0.7× 111 0.3× 188 2.1k
Mario Schiffer Germany 41 609 0.7× 3.3k 4.0× 2.3k 3.7× 482 1.2× 167 0.4× 246 7.0k
Kaoru Tabei Japan 27 462 0.5× 668 0.8× 849 1.4× 69 0.2× 247 0.6× 214 2.8k

Countries citing papers authored by Matti Nuutinen

Since Specialization
Citations

This map shows the geographic impact of Matti Nuutinen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matti Nuutinen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matti Nuutinen more than expected).

Fields of papers citing papers by Matti Nuutinen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matti Nuutinen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matti Nuutinen. The network helps show where Matti Nuutinen may publish in the future.

Co-authorship network of co-authors of Matti Nuutinen

This figure shows the co-authorship network connecting the top 25 collaborators of Matti Nuutinen. A scholar is included among the top collaborators of Matti Nuutinen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matti Nuutinen. Matti Nuutinen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vieira, Päivi, Elisa Rahikkala, Marja‐Leena Väisänen, et al.. (2021). Cytosolic phosphoenolpyruvate carboxykinase deficiency: Expanding the clinical phenotype and novel laboratory findings. Journal of Inherited Metabolic Disease. 45(2). 223–234. 9 indexed citations
2.
3.
Peräsaari, Juha, Ville Saarela, Janne Nikkilä, et al.. (2013). HLA associations with tubulointerstitial nephritis with or without uveitis in Finnish pediatric population: a nation‐wide study. Tissue Antigens. 81(6). 435–441. 22 indexed citations
4.
Jauhola, Outi, Jaana Ronkainen, Olli Koskimies, et al.. (2012). Outcome of Henoch–Schönlein purpura 8 years after treatment with a placebo or prednisone at disease onset. Pediatric Nephrology. 27(6). 933–939. 31 indexed citations
5.
Hurskainen, Tiina, Raija Sormunen, Claus-Werner Franzke, et al.. (2012). Transmembrane collagen XVII is a novel component of the glomerular filtration barrier. Cell and Tissue Research. 348(3). 579–588. 25 indexed citations
6.
Jahnukainen, Timo, Marja Ala‐Houhala, Riitta Karikoski, et al.. (2010). Clinical outcome and occurrence of uveitis in children with idiopathic tubulointerstitial nephritis. Pediatric Nephrology. 26(2). 291–299. 41 indexed citations
7.
Knip, Mikael, Antti Reunanen, Suvi Μ. Virtanen, et al.. (2008). Does the secular increase in body mass in children contribute to the increasing incidence of type 1 diabetes?. Pediatric Diabetes. 9(3pt2). 46–49. 33 indexed citations
8.
Uusimaa, Johanna, Jukka S. Moilanen, Leena Vainionpää, et al.. (2007). Prevalence, segregation, and phenotype of the mitochondrial DNA 3243A>G mutation in children. Annals of Neurology. 62(3). 278–287. 77 indexed citations
9.
Kaakinen, Timo, Sebastian Dahlbacka, Päivi Laurila, et al.. (2006). Fructose- 1,6-Bisphosphate Supports Cerebral Energy Metabolism in Pigs after Ischemic Brain Injury Caused by Experimental Particle Embolization. The Heart Surgery Forum. 9(6). E828–E835. 14 indexed citations
10.
Ludwig, Michael, Hannsjörg W. Seyberth, Arend Bökenkamp, et al.. (2005). Functional evaluation of Dent’s disease-causing mutations: implications for ClC-5 channel trafficking and internalization. Human Genetics. 117(2-3). 228–237. 44 indexed citations
11.
Romsi, Pekka, Timo Kaakinen, Kai Kiviluoma, et al.. (2003). Fructose-1,6-bisphosphate for improved outcome after hypothermic circulatory arrest in pigs. Journal of Thoracic and Cardiovascular Surgery. 125(3). 686–698. 12 indexed citations
12.
Taittonen, Leena, Matti Uhari, Juha Turtinen, & Matti Nuutinen. (1997). Change in Blood Pressure during Pubertal Insulin Resistance. Pediatric Research. 41(2). 272–275. 6 indexed citations
13.
Taittonen, Leena, Matti Nuutinen, Leena Räsänen, et al.. (1997). Lack of association between copper, zinc, selenium and blood pressure among healthy children. Journal of Human Hypertension. 11(7). 429–433. 15 indexed citations
14.
Uhari, Matti, Matti Nuutinen, & Juha Turtinen. (1996). Adverse reactions in children during long term antimicrobial therapy. The Pediatric Infectious Disease Journal. 15(5). 404–408. 43 indexed citations
15.
Nuutinen, Matti, et al.. (1996). Type of nappy and nursing habits in acquiring acute urinary tract infection. Acta Paediatrica. 85(9). 1039–1041. 7 indexed citations
16.
Nuutinen, Matti, K Kouvalainen, & Mikael Knip. (1995). Good growth response to growth hormone treatment in the ring chromosome 15 syndrome.. Journal of Medical Genetics. 32(6). 486–487. 21 indexed citations
17.
Giardina, Bruno, Roberto Scatena, Maria Elisabetta Clementi, et al.. (1993). Physiological Relevance of the Overall ΔH of Oxygen Binding to Fetal Human Hemoglobin. Journal of Molecular Biology. 229(2). 512–516. 18 indexed citations
18.
Giardina, Bruno, et al.. (1989). Arctic adaptation in reindeer The energy saving of a hemoglobin. FEBS Letters. 247(1). 135–138. 40 indexed citations
19.
Uhari, M & Matti Nuutinen. (1988). Epidemiology of symptomatic infections of the urinary tract in children.. BMJ. 297(6646). 450–452. 37 indexed citations
20.
Nuutinen, Matti, et al.. (1988). Comparison of health patterns in two geochemically contrasted areas of northern Finland. Environmental Geochemistry and Health. 10(3-4). 74–83. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. C. Atkins Breakdown of academic impact, for papers by Norman J. Siegel Breakdown of academic impact, for papers by Jun Oh Breakdown of academic impact, for papers by Masashi Mizuno Breakdown of academic impact, for papers by R. A. P. Koene Breakdown of academic impact, for papers by Marco Carini Breakdown of academic impact, for papers by Deborah P. Jones Breakdown of academic impact, for papers by G Richet Breakdown of academic impact, for papers by Mario Schiffer Breakdown of academic impact, for papers by Kaoru Tabei
Rankless by CCL
2026